You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Johnson and Johnson
McKesson
Mallinckrodt
Boehringer Ingelheim

Last Updated: February 22, 2024

Acer Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Acer
International Patents:147
US Patents:11
Tradenames:3
Ingredients:3
NDAs:3

Drugs and US Patents for Acer

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acer OLPRUVA sodium phenylbutyrate FOR SUSPENSION;ORAL 214860-002 Dec 22, 2022 RX Yes No 11,202,767 ⤷  Try a Trial ⤷  Try a Trial
Acerus Pharms NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 DISCN Yes No 9,539,302 ⤷  Try a Trial Y ⤷  Try a Trial
Acer OLPRUVA sodium phenylbutyrate FOR SUSPENSION;ORAL 214860-001 Dec 22, 2022 RX Yes No 11,202,767 ⤷  Try a Trial ⤷  Try a Trial
Acer OLPRUVA sodium phenylbutyrate FOR SUSPENSION;ORAL 214860-005 Dec 22, 2022 RX Yes No 11,433,041 ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Acer

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 8,574,622 ⤷  Try a Trial
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 8,877,230 ⤷  Try a Trial
Acerus Pharms NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 7,579,321 ⤷  Try a Trial
Acerus Pharms NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-002 Mar 3, 2017 7,579,321 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for Acer Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2712622 122017000006 Germany ⤷  Try a Trial PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504
3225249 CA 2019 00023 Denmark ⤷  Try a Trial PRODUCT NAME: DESMOPRESSIN ELLER ET ACETATSALT DERAF; NAT. REG. NO/DATE: 55858, 55859 (DK) 20160526; FIRST REG. NO/DATE: BE BE497271, BE497280 20160504
0145340 99C0005 Belgium ⤷  Try a Trial PRODUCT NAME: FOSPHENYTOIN DISODIUM; NAT. REGISTRATION NO/DATE: NL 23 613 19980806; FIRST REGISTRATION: GB - PL 000 19/0157 19980204
1856135 2090014-8 Sweden ⤷  Try a Trial PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE OR SOLVATE OF FOSTAMATINIB OR THE PH ARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REG. NO/DATE: EU/1/19/1405 20200113
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Colorcon
Boehringer Ingelheim
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.